Therapeutic Asset Ratings
290 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Azacitidine
Myelodysplastic Syndromes
The First Affiliated Hospital of Soochow University
P3
BB
(68)
METHOTREXATE
Chronic Myeloproliferative Disorders
The First Affiliated Hospital of Soochow University
P3
BB
(68)
METHOTREXATE
Myelodysplastic Syndromes
The First Affiliated Hospital of Soochow University
P3
BB
(68)
Venetoclax
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
The First Affiliated Hospital of Soochow University
P3
BB
(68)
Inno-206
Neoplasm
The First Affiliated Hospital of Soochow University
P2/3
BB
(68)
Cyclophosphamide
Hemophagocytic Lymphohistiocytosis
The First Affiliated Hospital of Soochow University
P4
BB
(67)
Monomethyl Fumarate
Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University
P3
BB
(67)
Vesanoid
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
P3
BB
(67)
cc-5013
Newly Diagnosed
The First Affiliated Hospital of Soochow University
P4
BB
(66)
cc-5013
Peripheral T-cell Lymphoma
The First Affiliated Hospital of Soochow University
P4
BB
(66)
DEXAMETHASONE
Newly Diagnosed
The First Affiliated Hospital of Soochow University
P4
BB
(66)
FILGRASTIM
High Risk
The First Affiliated Hospital of Soochow University
P4
BB
(66)
CIS-DIAMMINEDICHLOROPLATINUM II
MRD
The First Affiliated Hospital of Soochow University
P4
BB
(65)
PREDNISONE TABLETS
Hemophagocytic Lymphohistiocytosis
The First Affiliated Hospital of Soochow University
P4
BB
(65)
VINCRISTINE SULFATE
Hemophagocytic Lymphohistiocytosis
The First Affiliated Hospital of Soochow University
P4
BB
(65)
Zanubrutinib
Hemophagocytic Lymphohistiocytosis
The First Affiliated Hospital of Soochow University
P4
BB
(65)
Sorafenib
Acute Myeloid Leukemia With FLT3/ITD Mutation
The First Affiliated Hospital of Soochow University
P3
BB
(65)
Azacitidine
Allogeneic Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University
P2/3
BB
(65)
Bortezomib
High Risk
The First Affiliated Hospital of Soochow University
P4
BB
(64)
Bortezomib
Newly Diagnosed
The First Affiliated Hospital of Soochow University
P4
BB
(64)
Carfilzomib
MRD
The First Affiliated Hospital of Soochow University
P4
BB
(64)
cc-5013
High Risk
The First Affiliated Hospital of Soochow University
P4
BB
(64)
cc-5013
MRD
The First Affiliated Hospital of Soochow University
P4
BB
(64)
DARATUMUMAB
MRD
The First Affiliated Hospital of Soochow University
P4
BB
(64)
DEXAMETHASONE
High Risk
The First Affiliated Hospital of Soochow University
P4
BB
(64)
Showing 26 to 50 of 290 assets
Previous
Page 2 of 12
Next